Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the potential side effects of opdivo infusions?

See the DrugPatentWatch profile for opdivo

Common Side Effects During Infusion

Opdivo (nivolumab) infusions can trigger immediate reactions like fatigue, chills, fever, itching, rash, nausea, diarrhea, and low blood pressure. These often occur within hours of administration and affect over 10% of patients in clinical trials.[1][2]

Immune-Related Side Effects

As a PD-1 inhibitor, Opdivo boosts immune activity, which can attack healthy tissues. Frequent issues include:
- Skin: Rash, pruritus (up to 40% of patients).
- Gastrointestinal: Colitis, diarrhea (15-20%).
- Endocrine: Thyroid dysfunction, adrenal insufficiency (10-15%).
- Pulmonary: Pneumonitis (3-5%, potentially severe).
- Liver: Hepatitis (1-5%).
These may appear weeks to months after starting and require steroids or treatment pauses.[1][3]

Severe or Life-Threatening Reactions

Rare but serious effects hit 1-5% of users:
- Severe infusion reactions (anaphylaxis-like).
- Myocarditis or neurological issues like encephalitis.
- Toxic epidermal necrolysis or Stevens-Johnson syndrome.
Fatal outcomes occur in under 1% from organ inflammation.[2][4]

Side Effects by Cancer Type or Combination Therapy

Reactions intensify with combos like Opdivo + Yervoy (ipilimumab):
- Higher colitis (40%) and hepatitis (20%) rates.
Lung cancer patients see more pneumonitis; melanoma users report more skin issues. Long-term use (over 1 year) raises endocrine risks.[1][3]

What Happens if Side Effects Occur

Mild cases need monitoring; severe ones stop infusions and use immunosuppressants. Patients on blood thinners face bleeding risks from colitis. Regular blood tests track thyroid/liver function.[2]

Patient-Reported Experiences

Forum discussions highlight persistent fatigue (lasting months post-treatment), joint pain, and hypothyroidism requiring lifelong meds. Some recover fully after discontinuation.[4]

[1]: Opdivo Prescribing Information (Bristol Myers Squibb)
[2]: FDA Label for Nivolumab
[3]: NCCN Guidelines for Immunotherapy Toxicity
[4]: Cancer.gov - PD-1/PD-L1 Inhibitors Side Effects



Other Questions About Opdivo :

What are the side effects of Opdivo? How does opdivo compare to keytruda? What are the potential side effects of opdivo infusions? What are the side effects of the drug opdivo? What is the mechanism of action for the cancer drug opdivo? When will opdivo lose its patent exclusivity?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy